United Therapeutics Corporation logo
United Therapeutics Corporation UTHR
$ 358.67 -0.42%

Quarterly report 2024-Q3
added 10-30-2024

report update icon

United Therapeutics Corporation Balance Sheet 2011-2024 | UTHR

Annual Balance Sheet United Therapeutics Corporation

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- - - - 112 M 328 M -233 M -1.02 B -826 M -271 M 7.29 M 446 M 272 M

Long Term Debt

- - - - 600 M 250 M 250 M - - - 3.72 M 275 M 194 M

Long Term Debt Current

- - - - - - - - - - - - -

Total Non Current Liabilities

- - - - 670 M 317 M 314 M 131 M 144 M 115 M 95.6 M 355 M 357 M

Total Current Liabilities

804 M 343 M 305 M 323 M 463 M 277 M 445 M 332 M 441 M 504 M 688 M 177 M 213 M

Total Liabilities

1.18 B 1.25 B 1.21 B 1.22 B 1.13 B 593 M 758 M 463 M 585 M 619 M 783 M 532 M 570 M

Deferred Revenue

- - - - - - - - - - - - -

Retained Earnings

6.03 B 5.04 B 4.32 B 3.84 B 3.33 B 3.43 B 2.85 B 2.43 B 1.72 B 1.07 B 728 M 553 M 249 M

Total Assets

7.17 B 6.04 B 5.17 B 4.62 B 3.91 B 3.4 B 2.88 B 2.33 B 2.18 B 1.88 B 2.09 B 1.63 B 1.52 B

Cash and Cash Equivalents

1.21 B 961 M 895 M 739 M 738 M 669 M 705 M 1.02 B 832 M 398 M 284 M 159 M 163 M

Book Value

5.98 B 4.8 B 3.96 B 3.4 B 2.78 B 2.81 B 2.12 B 1.86 B 1.6 B 1.27 B 1.3 B 1.09 B 948 M

Total Shareholders Equity

5.98 B 4.8 B 3.96 B 3.4 B 2.78 B 2.79 B 2.1 B 1.85 B 1.59 B 1.24 B 1.26 B 1.08 B 948 M

All numbers in USD currency

Quarterly Balance Sheet United Therapeutics Corporation

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - - - - - - - - - - - - - - - - 3 M 2.8 M 4 M 3.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - 57.5 M 57.4 M - 131 M - 131 M - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

1.02 B 1.03 B 1.16 B 1.18 B 1.31 B 1.27 B 1.22 B 1.25 B 1.22 B - 1.18 B 1.21 B 1.22 B 1.21 B 1.2 B 1.22 B 1.22 B 1.22 B 1.22 B 1.13 B 1.13 B 1.13 B 1.13 B 593 M 593 M 593 M 593 M 758 M 758 M 758 M 758 M 463 M 463 M 463 M 463 M 585 M 585 M 585 M 585 M 619 M 619 M 619 M 619 M 783 M 783 M 783 M 783 M 532 M 532 M 532 M 532 M 559 M 559 M 559 M 559 M

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

6.92 B 6.61 B 6.33 B 6.03 B 5.81 B 5.54 B 5.28 B 5.04 B 4.91 B - 4.55 B 4.32 B 4.2 B 4.04 B 3.87 B 3.84 B 3.84 B 3.84 B 3.84 B 3.33 B 3.33 B 3.33 B 3.33 B 3.43 B 3.43 B 3.43 B 3.43 B 2.85 B 2.85 B 2.85 B 2.85 B 2.43 B 2.43 B 2.43 B 2.43 B 1.72 B 1.72 B 1.72 B 1.72 B 1.07 B 1.07 B 1.07 B 1.07 B 728 M 728 M 728 M 728 M 553 M 553 M 553 M 553 M 249 M 249 M 249 M 249 M

Total Assets

7.12 B 6.72 B 6.5 B 7.17 B 7.02 B 6.68 B 6.35 B 6.04 B 5.78 B - 5.36 B 5.17 B 5.05 B 4.84 B 4.64 B 4.62 B 4.62 B 4.62 B 4.62 B 3.91 B 3.91 B 3.91 B 3.91 B 3.4 B 3.4 B 3.4 B 3.4 B 2.88 B 2.88 B 2.88 B 2.88 B 2.33 B 2.33 B 2.33 B 2.33 B 2.18 B 2.18 B 2.18 B 2.18 B 1.88 B 1.88 B 1.88 B 1.88 B 2.09 B 2.09 B 2.09 B 2.09 B 1.63 B 1.63 B 1.63 B 1.63 B 1.52 B 1.52 B 1.52 B 1.52 B

Cash and Cash Equivalents

1.55 B 1.36 B 1.25 B 1.21 B 1.11 B 1.07 B 1.16 B 961 M 967 M 795 M 813 M 895 M 908 M 942 M 832 M 739 M 739 M 739 M 739 M 738 M 738 M 738 M 738 M 669 M 669 M 669 M 669 M 705 M 705 M 705 M 705 M 1.02 B 1.02 B 1.02 B 1.02 B 832 M 832 M 832 M 832 M 398 M 398 M 398 M 398 M 284 M 284 M 279 M 279 M 159 M 154 M 154 M 154 M 168 M 163 M 163 M 163 M

Book Value

6.1 B 5.7 B 5.34 B 5.98 B 5.71 B 5.41 B 5.12 B 4.8 B 4.56 B - 4.18 B 3.96 B 3.83 B 3.64 B 3.45 B 3.4 B 3.4 B 3.4 B 3.4 B 2.78 B 2.78 B 2.78 B 2.78 B 2.81 B 2.81 B 2.81 B 2.81 B 2.12 B 2.12 B 2.12 B 2.12 B 1.86 B 1.86 B 1.86 B 1.86 B 1.6 B 1.6 B 1.6 B 1.6 B 1.27 B 1.27 B 1.27 B 1.27 B 1.3 B 1.3 B 1.3 B 1.3 B 1.09 B 1.09 B 1.09 B 1.09 B 959 M 959 M 959 M 959 M

Total Shareholders Equity

6.1 B 5.7 B 5.34 B 5.98 B 5.71 B 5.41 B 5.12 B 4.8 B 4.56 B 4.32 B 4.18 B 3.96 B 3.83 B 3.64 B 3.45 B 3.4 B 3.4 B 3.4 B 3.4 B 2.78 B 2.78 B 2.78 B 2.78 B 2.79 B 2.79 B 2.79 B 2.79 B 2.1 B 2.1 B 2.1 B 2.1 B 1.85 B 1.85 B 1.85 B 1.85 B 1.59 B 1.59 B 1.59 B 1.59 B 1.24 B 1.24 B 1.24 B 1.24 B 1.26 B 1.26 B 1.26 B 1.26 B 1.08 B 1.08 B 1.08 B 1.08 B 948 M 948 M 948 M 948 M

All numbers in USD currency